Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: A longitudinal study of three influenza seasons in Japan

Microbiology and Immunology

Volumn 56, Issue 12, 2012, Pages 810-816

  Uno, Shingo ^a   Kimachi, Kazuhiko ^a   Matsuo, Fujio ^b   Miyazaki, Keiichiro ^a   Oohama, Ayano ^a   Kei, Junko ^a   Nishimura, Tomohiro ^a   Odoh, Koichi ^a   Kino, Yoichiro ^a  

^a Chemo Sero Therapeutic Research Institute   (Japan)

^b Statcom   (Japan)

Author keywords

Cross reactive antibody response; Longitudinal study; Pandemic H1N1 2009 vaccine; Seasonal influenza vaccine

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS A H1N1 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS REACTION; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LONGITUDINAL STUDY; MALE; SEASONAL INFLUENZA; SEROCONVERSION;

ADULT; ANTIBODIES, VIRAL; CROSS REACTIONS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED;

ORTHOMYXOVIRIDAE; SUIDAE;

EID: 84870323774     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2012.00511.x     Document Type: Article

References (24)

1. Shinde V., Bridges C.B., Uyeki T.U., Shu B., Balish A., Xu X., Lindstrom S., Gubareva L.V., Deyde V., Garten R.J., Harris M., Gerber, S., Vagoski S., Forrest Smith F., Pascoe N., Martin K., Dufficy D., Ritger K., Conover C., Patricia Quinlisk P., Klimov A., Bresee J.S., Finelli L. (2009) Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 360: 2616-25.
2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-15.
3. Rizzo C., Rota M.C., Bella A., Alfonsi V., Declich S., Caporali M.G., Ranghiasci A, Lapini G., Piccirella S., Salmaso S., Montomoli E. (2010) Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 28: 3558-62.
4. Ikonen N., Strengell M., Kinnunen L., Osterlund P., Pirhonen J., Broman M., Davidkin I., Ziegler T., Julkunen I. (2010) High frequency of cross-reacting antibodies against pandemic influenza A (H1N1) 2009 virus among the elderly in Finland. Euro Surveill 15: pii:19478.
5. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., Zambon M. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100-08.
6. Centers for Disease Control and Prevention (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morb Mortal Wkly Rep 58: 521-24.
7. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., Liu F., Dong L., DeVos J.R., Gargiullo P.M., Brammer T.L., Cox N.J., Tumpey T.M., Katz J.M. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-52.
8. Infectious Disease Surveillance Center (2010) 2009/10 influenza season, Japan. IASR 31: 248-50. Available from: http://idsc.nih.go.jp/iasr/31/367/tpc367.html.
9. Xie H., Jing X., Lin Z., Plant E., Zoueva O., Yang H., Ye Z. (2011) Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly. PLoS One 6: e16650.
10. Lee V.J., Tay J.K., Chen M.I., Phoon M.C., Xie M.L., Wu Y., Lee C.X., Yap J., Sakharkar K.R., Sakharkar M.K., Lin R.T., Cui L., Kelly P.M., Leo Y.S., Tan Y.J., Chow V.T. (2010) Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine 28: 6852-7.
11. Iorioa A.M., Camillonia B., Lepria E., Neria M., Basileoa M., Azzib A. (2011) Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). Procedia in Vaccinology 4: 50-8.
12. World Health Organization (2002) Department of Communicable Disease Surveillance and Response. WHO manual on animal influenza diagnosis and surveillance. Available from: http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf.
13. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). (2008) Guideline on Dossier Structure and Content for Pandemic Influenza Vaccine Marketing Authorisation. Application (Revision)., Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003869.pdf.
14. Johns M.C., Eick A.A., Blazes D.L., Lee S.E., Perdue C.L., Lipnick R., Vest K.G., Russell K.L., DeFraites R.F., Sanchez J.L. (2010) Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS One 5: e10722.
15. Orellano P.W., Reynoso J.I., Carlino O., Uez O. (2010) Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. Vaccine 28: 5288-91.
16. Skowronski D.M., De Serres G., Crowcroft N.S., Janjua N.Z., Boulianne N., Hottes T.S., Rosella L.C., Dickinson J.A., Gilca R., Sethi P., Ouhoummane N., Willison D.J., Rouleau I., Petric M., Fonseca K., Drews S.J., Rebbapragada A., Charest H., Hamelin M.E., Boivin G., Gardy J.L., Li Y., Kwindt T.L., Patrick D.M., Brunham R.C., Canadian SAVOIR Team. (2011) Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 7: e1000258.
17. Rosella L.C., Groenwold R.H., Crowcroft N.S. (2011) Assessing the impact of confounding (measured and unmeasured) in a case-control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine. Vaccine 29: 9194-200.
18. Kelly H.A., Grant K.A., Fielding J.E., Carville K.S, Looker C.O., Tran T, Jacoby P. (2011) Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine 26: 6419-26.
19. Yin J.K., Chow M.Y., Khandaker G., King C., Richmond P., Heron L., Booy R. (2012) Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: Systematic review and meta-analyses. Vaccine 30: 3209-22.
20. Iorio A.M., Bistoni. O., Galdiero M., Lepri E., Camilloni B., Russano A.M., Neri M., Basileo M., Spinozzi F. (2012) Influenza viruses and cross-reactivity in healthy adults: Humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus. Vaccine 30: 1617-23.
21. De Groot A.S., Ardito M., McClaine E.M., Moise L., Martin W.D. (2009) Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 27: 5740-47.
22. Weinfurter J. T., Brunner K., Capuano III S. V., Li C., Broman K. W., Kawaoka Y., Friedrich T.C. (2011) Cross-reactive T Cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. PLoS Pathog 7: e1002381.
23. Uno S., Kimachi K., Kei J., Miyazaki K., Oohama A., Nishimura T., Ibaragi K., Odoh K., Kudo Y., Kino Y. (2011) Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial. Microbiol Immunol 55: 783-9.
24. Wu J., Zhong X., Li C.K., Zhou J.F., Lu M., Huang K.Y., Dong M., Liu Y., Luo F.J., Du N., Chui C., Liu L.Q., Smith N.M., Li B., Shi N.M., Song L.F., Gao Y., Wang D.Y., Wang X., Zhu W.F., Yan Y., Li Z., Chen J.T., McMichael A.J., Yin W.D., Xu X.N., Shu Y. (2011) Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine 29: 1009-16.